Each of our systems have unique energy ranges, applicators, and treatment capabilities. Learn which of our radiotherapy systems is right for you and your patients by watching the video below. Our Chief Science Officer, Amanda Tulk, outlines the key differences of each...
It can be difficult to treat cancer of the eyelid. Treatment with surgery often leads to tissue loss. Superficial radiotherapy can be used, but typically involves a topical anesthetic and the user of an internal eye shield, which can present risks and challenges...
Skin cancer is an increasingly common condition, particularly keratinocytic cancers like basal cell carcinoma and cutaneous squamous cell carcinoma. Surgery has been the standard treatment for these, but affects functional and/or cosmetic outcomes. Definitive...
Clinicians use Xstrahl equipment to treat a variety of conditions Including non-melanoma skin cancer, and other benign and palliative applications.
Skin cancer is the most common cancer and the incidence is growing. Most are found in the head and neck. While surgery is the mainstay of treatment, it always leads to tissue sacrifice. New developments in radiotherapy (RT) have resulted in having almost similar...
Xstrahl 150 was successfully used to treat lentigo maligna with normal visual acuity post treatment and improved cosmesis.
Contact Us